Skip to main contentSkip to navigation
Sirius Investors

RPTX Financial Statements & Analysis

Complete financial statements for RPTX including income statement, balance sheet, and cash flow statement. Analyze RPTX's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Financial Health Score

Financial Health Score

/100
Unlock score for free

Already registered? Sign in

Income Statement

Revenue
4648.0%
Net Income
34.3%
Gross Margin
103.1%
Operating Margin
98.6%

Balance Sheet

Current Ratio
69.9%
Debt to Equity
-49.5%
Asset Turnover
4788.3%

Cash Flow

Operating Cash Flow
32.1%
Net Cash Flow
36.6%
Free Cash Flow
32.1%
Cash Flow to Debt
-28.8%

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q2 '25TTM Q3 '25ChangeImpact
Revenue250.00K11.87M4648.0%
Gross Profit-1.87M2.73M246.0%
Operating Income-110.83M-75.09M32.2%
Net Income-109.86M-72.20M34.3%
EPS-0.64-0.4234.5%
EBITDA-108.66M-75.81M30.2%
Gross Margin-747.20%22.98%103.1%
Operating Margin-44332.00%-632.62%98.6%
Net Income Margin-43945.60%-608.26%98.6%
R&D Expenses85.27M65.09M23.7%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q3 '25TTM Q2 '25TTM Q1 '25TTM Q4 '24TTM Q3 '24
Revenue11.87M250.00K1.07M
Gross Profit2.73M-1.87M-1.53M
Operating Income-75.09M-110.83M-130.11M
Net Income-72.20M-109.86M-127.89M
EPS-0.42-0.64-0.75
EBITDA-75.81M-108.66M-123.33M
Gross Margin22.98%-747.20%-142.87%
Operating Margin-632.62%-44332.00%-12125.72%
Net Income Margin-608.26%-43945.60%-11919.29%
R&D Expenses65.09M85.27M100.32M

Our detailed financial analysis helps investors understand RPTX's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track RPTX's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into RPTX's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics
Repare Therapeutics Inc. (RPTX) Financial Statements (2026): Income, Balance Sheet & Cash Flow | Sirius Investors